In last trading session, LENZ Therapeutics Inc (NASDAQ:LENZ) saw 0.76 million shares changing hands with its beta currently measuring 0.66. Company’s recent per share price level of $32.63 trading at $2.35 or 7.76% at ring of the bell on the day assigns it a market valuation of $897.36M. That closing price of LENZ’s stock is at a discount of -19.31% from its 52-week high price of $38.93 and is indicating a premium of 67.12% from its 52-week low price of $10.73. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 160.15K if we extend that period to 3-months.
For LENZ Therapeutics Inc (LENZ), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.14. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.4 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LENZ Therapeutics Inc (NASDAQ:LENZ) trade information
Upright in the green during last session for gaining 7.76%, in the last five days LENZ remained trading in the green while hitting it’s week-highest on Friday, 12/20/24 when the stock touched $32.63 price level, adding 3.58% to its value on the day. LENZ Therapeutics Inc’s shares saw a change of 163.15% in year-to-date performance and have moved 5.36% in past 5-day. LENZ Therapeutics Inc (NASDAQ:LENZ) showed a performance of -3.77% in past 30-days. Number of shares sold short was 2.27 million shares which calculate 14.91 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 34 to the stock, which implies a rise of 4.03% to its current value. Analysts have been projecting 32 as a low price target for the stock while placing it at a high target of 36. It follows that stock’s current price would jump 1.93% in reaching the projected high whereas dropping to the targeted low would mean a gain of 1.93% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -483.52% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 65.49% while estimates for its earnings growth in next 5 years are of 38.53%.
